| Literature DB >> 28686996 |
T Srinivasa Reddy1, Steven H Privér1, Nedaossadat Mirzadeh2, Suresh K Bhargava3.
Abstract
We report the application of cationic tri- and tetra-nuclear gold(I) phosphine complexes [Au3(μ-dppen)3]X3 and [Au4(μ-dppa)4]X4 (X=OTf, PF6) [OTf=trifluoromethanesulfonate, dppen=trans-1,2-bis(diphenylphosphino)ethene, dppa=bis(diphenylphosphino)acetylene] for cancer treatment. The results of cytotoxicity tests on four different cancer cells [prostate (DU145), cervical (HeLa), breast (MDAMB-231) and fibro sarcoma (HT1080)] indicate these complexes possess remarkable tumor cell growth inhibitory effects and high selectivity towards cancer cells. The anti-tumor mechanism of the tri- and tetra-nuclear gold(I) complexes has also been investigated.Entities:
Keywords: Anti-cancer activity; Apoptosis; Gold phosphine complexes; Thioredoxin reductase
Mesh:
Substances:
Year: 2017 PMID: 28686996 DOI: 10.1016/j.jinorgbio.2017.06.010
Source DB: PubMed Journal: J Inorg Biochem ISSN: 0162-0134 Impact factor: 4.155